The Ibex 35 (+ 1%) closed September asking for the time and saving at least 6,700 points. Its distancing from the rest of the European parks has become more than evident, with the selective falling twice as much as its peers on the Old Continent both in the month and in the year.
- 11.154,600
- 1,56%
The advance that Asian stocks and US futures are registering seem to be reason enough to spur the Ibex 35.
To this it adds the Spanish manufacturing PMI which, despite the small print highlighted by IHS Markit experts, has returned to expansion and increases in September. The selective is also being supported by the nature of the entire first day of the month , which is usually supported by institutional purchases.
In the macro sphere, this Thursday will also be published the unemployment rate (and the manufacturing PMI) of the Eurozone and the weekly unemployment claims in the US.
From Banco Sabadell they expect "slight gains that should increase, driven by the growth profile sectors due to the good progress of the negotiations of the fiscal package in the US".
In business and health matters, Moderna is back in the news after acknowledging that its vaccine will not be distributed to the population until, at least, spring 2021. It is then that the pharmaceutical company plans to obtain the approval of the US Food and Drug Administration for marketing.
Noticias relacionadas
Berkeley identifica cinco riesgos que amenazan con truncar su reinado en bolsa
La vacuna de Moderna "no estará disponible antes de las elecciones de EEUU"
Sacyr libera presión bajista: el fondo Citadel suelta parte de su posición corta
